Search Results - "Guinea, José‐María"

Acute Monoblastic Leukemia with Erythrophagocytosis and Absence of KAT6A Rearrangement by Sánchez, Carlos De Miguel, de Castro, Diego Robles, de Viñaspre, Ana Vega González, Zilaurren, Ariane Unamunzaga, Abad, Arantza Mendizábal, de Castro, José María Guinea

“…A 44-year-old woman presented with fever and arthralgia. Her past medical history included ulcerative colitis, which was treated with azathioprine and…”
Get full text

Diffuse bone marrow metastases of small cell carcinoma with associated erythrophagocytosis mimicking acute leukaemia by De Miguel Sánchez, Carlos, Robles de Castro, Diego, Córdoba Alonso, Ana Isabel, Guinea de Castro, José María

Get full text

Management of Adult Patients with Primary Immune Thrombocytopenia (ITP) in Clinical Practice: A Consensus Approach of the Spanish ITP Expert Group by Ferreiras, David Valcárcel, González Porras, José Ramón, Sánchez González, Blanca, López-Fernández, M. Fernanda, Jarque, Isidro, Guinea de Castro, José María, González-López, Tomás José, Fernández Fuertes, Luis Fernando, Alvarez-Roman, M. Teresa, Mingot-Castellano, María Eva, Lozano, Maria Luisa

“…Background and Objective. Diagnosis and management of primary immune thrombocytopenia (ITP) have changed dramatically in the last decade. The aim of the study…”
Get full text

Recommendations on the Management of Patients with Immune Thrombocytopenia (ITP) in the Context of SARS-CoV-2 Infection and Vaccination: Consensus Guidelines from a Spanish ITP Expert Group by González-López, Tomás José, Bárez, Abelardo, Bernardo-Gutiérrez, Angel, Bernat, Silvia, Canaro-Hirnyk, Mariana, Entrena-Ureña, Laura, Fernández-Fuertes, Fernando, Guinea de Castro, José María, Jiménez-Bárcenas, Reyes, Pascual-Izquierdo, Cristina, Sánchez-González, Blanca, Jarque, Isidro

“…Primary immune thrombocytopenia (ITP) is an acquired autoimmune disease with highly variable presentation, characteristics, and clinical course…”
Get full text

Cost-Effectiveness Analysis of Gemtuzumab Ozogamicin for First-Line Treatment of Patients with Cd-33 Positive Acute Myeloid Leukaemia in Spain by Mareque, Maria, Montesinos, Pau, Font, Patricia, Guinea, José María, de la Fuente, Adolfo, Soto, Javier, Oyagüez, Itziar, Brockbank, James, Iglesias, Tamara, Llinares, Julia, Sierra, Jorge

“…To assess the incremental cost-utility ratio (ICUR) of gemtuzumab ozogamicin (GO) + standard of care (SOC) vs SOC alone for treatment of patients with AML from…”
Get full text

Bosutinib shows low cross intolerance, in chronic myeloid leukemia patients treated in fourth line. Results of the Spanish compassionate use program by García‐Gutiérrez, Valentín, Martinez‐Trillos, Alejandra, Lopez Lorenzo, Jose Luis, Bautista, Guiomar, Martin Mateos, Maria Luisa, Alvarez‐Larrán, Alberto, Iglesias Pérez, Ana, Romo Collado, Andrés, Fernandez, Angeles, Portero, Angeles, Cuevas, Beatriz, Ruiz, Concepción, Romero, Esperanza, Ortega, Fernando, Mata, Isabel, Tallón, José, García Garay, Maria del Carmen, Ramirez Sánchez, María José, de las Heras, Natalia, Giraldo, Pilar, Bobillo, Sabela, Guinea, José María, Deben, Guillermo, Valencia, Sandra, Sebrango, Ana, Boqué, Concepción, Maestro, Begoña, Steegmann, Juan Luis

“…The role of bosutinib as rescue treatment of Philadelphia chromosome‐positive chronic myeloid leukemia (CML) patients after failing three previous tyrosine…”
Get full text

Comparison of Intensive Chemotherapy, Allogeneic, or Autologous Stem-Cell Transplantation As Postremission Treatment for Children With Very High Risk Acute Lymphoblastic Leukemia: PETHEMA ALL-93 Trial by Ribera, Jose-Maria, Ortega, Juan-José, Oriol, Albert, Bastida, Pilar, Calvo, Carlota, Pérez-Hurtado, José-María, González-Valentín, María-Elvira, Martín-Reina, Victoria, Molinés, Antonio, Ortega-Rivas, Fernando, Moreno, Maria-José, Rivas, Concepción, Egurbide, Izaskun, Heras, Inmaculada, Poderós, Concepción, Martínez-Revuelta, Eva, Guinea, José-Maria, del Potro, Eloy, Deben, Guillermo

“…The optimal postremission therapy for children with very high-risk (VHR) acute lymphoblastic leukemia (ALL) is not well established. This randomized trial…”
Get full text

Safety and efficacy of bosutinib in fourth-line therapy of chronic myeloid leukemia patients by García-Gutiérrez, Valentín, Milojkovic, Dragana, Hernandez-Boluda, Juan Carlos, Claudiani, Simone, Martin Mateos, María Luisa, Casado-Montero, Luis Felipe, González, Gloria, Jimenez-Velasco, Antonio, Boque, Concepcion, Martinez-Trillos, Alejandra, Vázquez, Isabel Mata, Payer, Ángel Ramírez, Senín, Alicia, Amustio Díez, Elena, García, Abelardo Bárez, Carrascosa, Guiomar Bautista, Ortí, Guillermo, Ruiz, Beatriz Cuevas, Fernández, Maria Ángeles, del Carmen García Garay, María, Giraldo, Pilar, Guinea, Jose María, De Las Heras Rodríguez, Natalia, Hernán, Nuria, Pérez, Ana Iglesias, Piris-Villaespesa, Miguel, Lorenzo, Jose Luis López, Martí-Tutusaus, Josep Maria Martí, Vallansot, Rolando Omar, Ortega Rivas, Fernando, Puerta, Jose Manuel, Ramirez, Maria Jose, Romero, Esperanza, Romo, Andres, Rosell, Ana, Saavedra, Silvanna Saavedra, Sebrango, Ana, Tallon, José, Valencia, Sandra, Portero, Angeles, Steegmann, Juan Luis

“…Bosutinib is a second-generation tyrosine kinase inhibitor (2GTKI) approved at 400 mg once daily (QD) as first-line therapy in patients with chronic myeloid…”
Get full text

R‐COMP versus R‐CHOP as first‐line therapy for diffuse large B‐cell lymphoma in patients ≥60 years: Results of a randomized phase 2 study from the Spanish GELTAMO group by Sancho, Juan‐Manuel, Fernández‐Alvarez, Rubén, Gual‐Capllonch, Francisco, González‐García, Esther, Grande, Carlos, Gutiérrez, Norma, Peñarrubia, María‐Jesús, Batlle‐López, Ana, González‐Barca, Eva, Guinea, José‐María, Gimeno, Eva, Peñalver, Francisco‐Javier, Fuertes, Miguel, Bastos, Mariana, Hernández‐Rivas, José‐Ángel, Moraleda, José‐María, García, Olga, Sorigué, Marc, Martin, Alejandro

“…The use of non‐pegylated liposomal doxorubicin (Myocet®) in diffuse large B‐cell lymphoma (DLBCL) has been investigated in retrospective and single‐arm…”
Get full text

Velcadito: Low dose of bortezomib with melphalan and prednisone for ≥75‐year‐olds newly diagnosed with multiple myeloma by Pérez‐Persona, Ernesto, Oiartzabal‐Ormategui, Itziar, Herraez, Susana, Menchaca, Carmen, Cuevas‐Palomares, Laida, Santamaría‐López, Ana, Díez‐Angulo, Rosana, Robles‐Castro, Diego, Miguel‐Sánchez, Carlos, Gabilondo‐Jalón, Miren, Pisón‐Herrero, Carlos, Unamunzaga‐Cilaurren, Ariane, Vega González‐Viñaspre, Ana, Salcedo‐Cuesta, Laura, Mendizabal‐Abad, Arantza, Guinea de Castro, José María

Get full text

Real-life clinical practice in Spain in the setting of new drug availability for ITP treatment. A Delphi-based Spanish expert panel consensus by González-López, Tomás José, Bárez, Abelardo, Bernardo-Gutiérrez, Ángel, Bernat, Silvia, Fernández-Fuertes, Fernando, Guinea de Castro, José María, Jiménez-Bárcenas, Reyes, Jarque, Isidro

“…Immune thrombocytopenia (ITP) is a common autoimmune hematological disorder. Despite this, diagnosis is still challenging due to clinical heterogeneity and the…”
Get full text

Treatment burden in multiple myeloma according to comorbidity in real life by Pérez Persona, Ernesto, Oiartzabal Ormategui, Itziar, Cuevas Palomares, Laida, Santamaría López, Ana, Robles de Castro, Diego, Miguel de Sánchez, Carlos, Gabilondo Jalón, Miren, Pisón Herrero, Carlos, Unamunzaga Cilaurren, Ariane, Vega González de Viñaspre, Ana, Guinea de Castro, Jose María

Get full text

Ultrafast 30-min infusion of a rituximab biosimilar (Truxima) by Pérez-Persona, Ernesto, Cuevas Palomares, Laida, Unamunzaga Cilaurren, Ariane, Gutiérrez López de Ocáriz, Xabier, Buendía Ureña, Buenaventura, Vega González de Viñaspre, Ana, Benito Ibarrondo, Begoña, Molinillo Fernández, María Carmen, Cordero Osúa, Ana, Benítez Delgado, Beatriz, García Albás, Juan José, Andrés Moralejo, Miguel Ángel, Guinea de Castro, José María

“…In this clinical trial, we demonstrate that ultrarapid fast infusion of rituximab (Truxima) in 30 min with oral premedication is feasible and secure for…”
Get full text

Cost-Effectiveness Analysis of Gemtuzumab Ozogamicin for First-Line Treatment of Patients with Cd-33 Positive Acute Myeloid Leukaemia in Spain [Corrigendum] by Mareque, Maria, Montesinos, Pau, Font, Patricia, Guinea, José María, de la Fuente, Adolfo, Soto, Javier, Oyagüez, Itziar, Brockbank, James, Iglesias, Tamara, Llinares, Julia, Sierra, Jorge

“…Mareque M, Montesinos P, Font P, et al. Clinicoecon Outcomes Res. 2021;13:263-277. Page 271, Results, Base Case, second line from the bottom, the text "€…”
Get full text

Impact of the subcutaneous formulations of trastuzumab and rituximab on efficiency and resource optimization in Spanish hospitals: H-Excelencia study by Abad-Sazatornil, María Reyes, Arenaza, Ainhoa, Bayo, Juan, García Mata, Jesus, Guinea De Castro, José María, León, Josefa, Letellez, Javier, Reguero, Virginia, Martínez Chamorro, Carmen, Salar, Antonio

“…Subcutaneous (SC) versus intravenous (IV) administration is advantageous in terms of patient convenience and hospital efficiency. This study aimed to compare…”
Get full text

Bosutinib Apears to be Safe, with Low Cross Intolerance, in Patients Treated in 4th Line. Results of the Spanish Compassionate Use Program by García-Gutiérrez, Valentín, Maestro, Begoña, Martinez-Trillo, Alejandra, Lopez Lorenzo, Jose Luis, Martin Mateos, Maria Luisa, Alvarez, Alberto, Iglesias Pérez, Ana, Romo Collado, Andrés, Fernandez, Angeles, Bautista, Guiomar, Portero, Angeles, Cuevas, Beatriz, Ruiz, Concepción, Romero, Esperanza, Ortega, Fernando, Mata, Isabel, Tallón, José, García Garay, Maria del Carmen, Ramirez Sánchez, María José, de las Heras, Natalia, Giraldo, Pilar, Bobillo, Sabela, Guinea, José María, Deben, Guillermo, Valencia, Sandra, Sebrango, Ana, Boqué, Concepción, Steegmann, Juan Luis

“…Second-generation TKIs have demonstrated efficacy and an acceptable tolerability in patients (pts) with chronic myeloid leukemia (CML); however, new data from…”
Get full text

Bosutinib shows low cross intolerance, in chronic myeloid leukemia patients treated in fourth line. Results of the S panish compassionate use program by García‐Gutiérrez, Valentín, Martinez‐Trillos, Alejandra, Lopez Lorenzo, Jose Luis, Bautista, Guiomar, Martin Mateos, Maria Luisa, Alvarez‐Larrán, Alberto, Iglesias Pérez, Ana, Romo Collado, Andrés, Fernandez, Angeles, Portero, Angeles, Cuevas, Beatriz, Ruiz, Concepción, Romero, Esperanza, Ortega, Fernando, Mata, Isabel, Tallón, José, García Garay, Maria del Carmen, Ramirez Sánchez, María José, de las Heras, Natalia, Giraldo, Pilar, Bobillo, Sabela, Guinea, José María, Deben, Guillermo, Valencia, Sandra, Sebrango, Ana, Boqué, Concepción, Maestro, Begoña, Steegmann, Juan Luis

“…The role of bosutinib as rescue treatment of Philadelphia chromosome‐positive chronic myeloid leukemia (CML) patients after failing three previous tyrosine…”
Get full text

Faggot cells in therapy‐related acute myeloid leukemia with inv(16) by Vega González de Viñaspre, Ana, De Miguel Sánchez, Carlos, Robles De Castro, Diego, Roldán Galiacho, Verónica, Mendizabal Abad, Arantza, Guinea De Castro, José María

“…Faggot cells are an uncommon finding in nonacute promyelocytic leukemia, even rarer when observed in mature granulocytic cells. Inv(16) should be dismissed…”
Get full text

Txagorrapid: Ultrarapid infusion in 30 minutes of the biosimilar of rituximab truxima—A cohort study by Perez Persona, Ernesto, Cuevas Palomares, Laida, Unamunzaga Cilaurren, Ariane, Gutierrez López de Gutierrez, Xabier, Buendía Ureña, Buenaventura, Molinillo Fernández, Carmen Luisa, Benito Ibarrondo, Begoña, Cordero Osua, Ana Isabel, Benítez Delgado, Beatriz, Andrés Moralejo, Miguel Angel, García Albás, Juan José, Guinea de Castro, José María

“…e13638 Background: Rituximab (anti-CD20 Ab) is the cornerstone of the treatment of non-Hodgkin B lymphomas. Infusion-related reactions (IRR) are the most…”
Get full text

Real-Life Multicenter Experience of the Use of Avatrombopag by Fernández Pérez, Mónica, Gutiérrez López de Ocariz, Xabier, Pisón Herrero, Carlos, Pereda Vicandi, Angel, Gabilondo Jalon, Miren, Guinea de Castro, Jose María, Ojinaga Begoña, Maria José, Moreto Quintana, Ana, García-Ruiz, Juan Carlos, Suarez Merchan, Edwin Uriel, Sierra-Aisa, Cristina

“…INTRODUCTION: Avatrombopag is a thrombopoietin receptor agonist (TPO-RA) indicated for the treatment of severe thrombocytopenia in adult patients with chronic…”
Get full text